ABIVAX Expands Its Antiviral Portfolio with Compounds Targeting Zika Virus
Go back to ABIVAX Expands Its Antiviral Portfolio with Compounds Targeting Zika Virus| (NASDAQ: ABVX) | Delayed: 113.67 +1.94 (1.74%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $111.73 | 52 Week High | $ | |||
| Open | $111.00 | 52 Week Low | $ | |||
| Day High | $115.11 | P/E | N/A | |||
| Day Low | $110.22 | EPS | $ | |||
| Volume | 991,481 | |||||

